Daiwa Securities Group Inc. - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 106 filers reported holding SURFACE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q3 2022$0770.0%0.00%
Q2 2022$0770.0%0.00%
Q1 2022$0770.0%0.00%
Q4 2021$0
-100.0%
770.0%0.00%
Q3 2021$1,0000.0%770.0%0.00%
Q2 2021$1,0000.0%770.0%0.00%
Q1 2021$1,0000.0%770.0%0.00%
Q4 2020$1,00077
-57.5%
0.00%
Q3 2019$0
-100.0%
1810.0%0.00%
Q2 2019$1,0000.0%1810.0%0.00%
Q1 2019$1,0001810.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$21,972,0003.87%
ACT CAPITAL MANAGEMENT, LLC 170,500$1,272,0000.65%
Parkman Healthcare Partners LLC 228,267$1,703,0000.37%
SILVERARC CAPITAL MANAGEMENT, LLC 94,539$705,0000.31%
C M BIDWELL & ASSOCIATES LTD 33,030$246,0000.16%
GSA CAPITAL PARTNERS LLP 115,147$859,0000.10%
Knights of Columbus Asset Advisors LLC 113,594$847,0000.08%
ARK Investment Management 4,478,546$33,410,0000.06%
Ipswich Investment Management Co., Inc. 32,000$239,0000.06%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 27,400$204,0000.04%
View complete list of SURFACE ONCOLOGY INC shareholders